Cargando…
Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development
BACKGROUND: Graft-versus-host disease (GvHD) remains the major obstacle to successful allogeneic hematopoietic stem cell transplantation, despite of the immunosuppressive regimens administered to control T cell alloreactivity. PI3K/AKT/mTOR pathway is crucial in T cell activation and function and, t...
Autores principales: | Herrero-Sánchez, Mª Carmen, Rodríguez-Serrano, Concepción, Almeida, Julia, San Segundo, Laura, Inogés, Susana, Santos-Briz, Ángel, García-Briñón, Jesús, Corchete, Luis Antonio, San Miguel, Jesús F., del Cañizo, Consuelo, Blanco, Belén |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072323/ https://www.ncbi.nlm.nih.gov/pubmed/27765055 http://dx.doi.org/10.1186/s13045-016-0343-5 |
Ejemplares similares
-
Bone Marrow Mesenchymal Stem Cells for Improving Hematopoietic Function: An In Vitro and In Vivo Model. Part 2: Effect on Bone Marrow Microenvironment
por: Carrancio, Soraya, et al.
Publicado: (2011) -
PI3K/AKT/mTOR Pathway in Angiogenesis
por: Karar, Jayashree, et al.
Publicado: (2011) -
MOB kinase activator 1A acts as an oncogene by targeting PI3K/AKT/mTOR in ovarian cancer
por: Lei, Jian, et al.
Publicado: (2023) -
Targeting PI3K/Akt/mTOR Signaling in Cancer
por: Porta, Camillo, et al.
Publicado: (2014) -
PI3K/Akt/mTOR inhibitors in breast cancer
por: Lee, Joycelyn JX, et al.
Publicado: (2015)